title: Parvovirus B19 infection and myofasciitis.
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Ichinose
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Migita
authors.forename: Takaharu
authors.initials: T
authors.lastname: Sekita
authors.forename: Hisayuki
authors.initials: H
authors.lastname: Hamada
authors.forename: Hironori
authors.initials: H
authors.lastname: Ezaki
authors.forename: Shigeaki
authors.initials: S
authors.lastname: Mukoubara
authors.forename: Katsumi
authors.initials: K
authors.lastname: Eguchi
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D005208:Fasciitis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D018482:Muscle, Skeletal / Q000473:pathology; D009220:Myositis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D010322:Parvoviridae Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D010666:Phenylpropionates / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010666:Phenylpropionates; C040656:loxoprofen